Deerfield Imaging announced last week that it has completed its acquisition of “certain assets and liabilities” of IMRIS, a company that specializes in image-guided therapy and had filed for bankruptcy.

Deerfield Imaging is a wholly owned business of Deerfield Management Company, a healthcare investment firm that had been working with IMRIS since 2013.

Jay D. Miller, Deerfield Imaging President and CEO, said his company is excited that the deal is now finalized, and that IMRIS has a great reputation within the industry.

“Top neuroscience centers equate the IMRIS brand with turnkey design services, program management, and clinical training that delivers smooth integration of imaging in the operating room,” Miller said in a statement. “Deerfield Imaging will continue developing new products under the IMRIS brand and invest in clinical studies to demonstrate the clinical and economic value of IMRIS surgical solutions.”

Teb Huber, a partner at Deerfield Management, also commented on the deal, praising the legacy of IMRIS’ VISIUS Surgical Theatre.

“IMRIS is enhancing the quality of neurosurgical procedures and improving patient outcomes,” he said. “Nearly 20,000 patients have benefitted from procedures in VISIUS Surgical Theatres and we look forward to seeing that number continue to grow.”